Pasithea Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $649 |
Gross Profit | -181 | -161 | -161 | -162 |
EBITDA | -2,855 | -3,649 | -3,517 | -3,015 |
EBIT | -3,037 | -3,810 | -3,679 | -3,177 |
Net Income | -3,037 | -3,716 | -3,563 | -3,177 |
Net Change In Cash | 0 | 0 | 0 | 649 |
Free Cash Flow | -2,890 | -3,868 | -3,055 | -2,443 |
Cash | 4,122 | 7,217 | 5,341 | 6,922 |
Basic Shares | 7,444 | 5,641 | 1,096 | 1,096 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $486 | $486 | $15 |
Gross Profit | -649 | -648 | -5 | -2 |
EBITDA | -13,600 | -15,330 | -11,722 | -4,506 |
EBIT | -14,249 | -15,979 | -11,727 | -4,507 |
Net Income | -13,904 | -15,961 | -13,936 | -2,173 |
Net Change In Cash | 0 | 486 | 486 | 15 |
Free Cash Flow | -13,923 | -13,459 | -13,798 | -3,195 |
Cash | 6,922 | 16,331 | 33,087 | 52,966 |
Basic Shares | 1,096 | 1,226 | 1,262 | 1,150 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.66 |
2025-03-31 | -$1.61 |
2024-12-31 | -$2.53 |
2024-09-30 | -$2.87 |
